McGill University researchers have developed an artificial intelligence tool that can identify small groups of cells most responsible for driving aggressive cancers.
Researchers from Children’s Hospital of Philadelphia (CHOP) developed a new RNA sequencing strategy that can reveal how genetic variants disrupt gene function and improve the diagnosis of rare diseases.
A natural compound made by Australian bees to seal their hives may help stop scarring in human skin after surgery, injury and burns.
A national study led by investigators from Cedars-Sinai Health Sciences University found that transcatheter tricuspid valve replacement, or TTVR, delivered strong early results in real-world practice.
A study by investigators at Mass General Brigham has found that a blood test of plasma phosphorylated tau 217 (pTau217), an Alzheimer’s disease biomarker, can predict the progression of amyloid PET scan changes and cognitive decline in cognitively healthy older adults.
Scientists have taken an important step toward a gene therapy that could one day turn off the extra genetic material that causes Down syndrome (DS)
A new study suggests a simple letter change can reverse sex development, causing a mouse with female chromosomes (XX) to develop male genitalia.
Phase 2 randomized trial shows 38% reduction in risk of death with the drug when combined with chemotherapy
A research team has developed a “self-regulating OLED wound healing patch” that combines light and drugs to pull up the wound recovery speed by about twice.
A major multi-site clinical trial co-led by researchers at Washington University School of Medicine in St. Louis has shown that post-thrombotic syndrome—a common and often painful complication suffered by many people who have experienced blockages of major veins due to blood clots—can be effectively treated with a minimally invasive procedure.